4Filing Date: Sep 14, 2026
Edwards Lifesciences (EW)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-007811
Total Value$21.3K
Trades1
Insiders1
Transaction Details
Dahl Andrew M.
SVP, Corporate Controller·Direct
Tax W/H · Dispose
Common Stock
Shares-253
Price$84.37
Total Value$21.3K
Shares Owned After14.62K
Transaction DateSep 13, 2026
Footnotes ▸
Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Post-Transaction Holdings
Dahl Andrew M. · SVP, Corporate Controller
| Security | Shares | Change |
|---|---|---|
| Common Stock | 14.62K | -253 (-1.70%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-13
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Dahl Andrew M.
CIK: 0002022347
Role: Officer (SVP, Corporate Controller)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-13 | Code: F (Payment of exercise/tax)
Shares: -253 | Price: $84.37
Total Value: $21,345.61
Shares Owned After: 14,615.41 | Ownership: D (Direct)
Footnotes:
[F1] Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
--- Footnotes (Complete Index) ---
F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-09-14)